Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Forest Laboratories

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Forest Laboratories 2013 CNS and cardiovascular sales performance.

Forest Laboratories

Positive trial results for Janssen’s Symtuza boosts its HIV credentials

Positive trial results for Janssen’s Symtuza boosts its HIV credentials laboratory parameters compared to F/TDF (emtricitabine/tenofovir disproxil fumarate).

Janssen’s quest to prevent diseases taking hold

Janssen’s quest to prevent diseases taking hold If you pick up the right biomarkers we can deal with them before they become forest fires.”. ... Its continuing work on Ebola has seen laboratory results that suppress the virus over 18 months and increased promise of an effective vaccine.

MSD touts Keytruda first-line promise in NSCLC

MSD touts Keytruda first-line promise in NSCLC NICE. Dr Roger Dansey, senior vice president and therapeutic area head, oncology late-stage development, Merck Research Laboratories, said: “With these findings from KEYNOTE-024, we continue to demonstrate the potential

The patient’s world is ‘messy’

The patient’s world is ‘messy’ Your drugs ‘live’ with them in a world which is messier than a laboratory but it is the real world and that is what needs to be taken into account.

Europe’s cancer drug regulation is ‘broken’, claims study

Europe’s cancer drug regulation is ‘broken’, claims study It added: “To help determine how medicines will function in a real world setting surrogate endpoints - often laboratory tests indicative of an expected improvement - often employed as clinical endpoints are less

[ Previous 5 results ] 18 19 20 21 22 23 24 25 26 27 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

DEMAND DIVERSITY REPORT 01: Exploring attitudes towards clinical research among people from different ethnic groups in the UK
This report reveals insights from the people themselves, and discusses the starting points for overcoming current challenges....
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative...
OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses...

Infographics